{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:01:06Z","timestamp":1791874866162,"version":"4.3.4"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020771","name":"Natural Science Foundation for Young Scientists of Shanxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Heart failure caused by pressure overload is one of the leading causes of heart failure worldwide, but its pathological origin remains poorly understood. It remains critical to discover and find new improvements and treatments for pressure overload-induced heart failure. According to previous studies, mitochondrial dysfunction and myocardial interstitial fibrosis are important mechanisms for the development of heart failure. The oligopeptide Szeto-Schiller Compound 31 (SS31) can specifically interact with the inner mitochondrial membrane and affect the integrity of the inner mitochondrial membrane. Whether SS31 alleviates pressure overload-induced heart failure through the regulation of mitochondrial fusion has not yet been confirmed. We established a pressure-overloaded heart failure mouse model through TAC surgery and found that SS31 can significantly improve cardiac function, reduce myocardial interstitial fibrosis, and increase the expression of optic atrophy-associated protein 1 (OPA1), a key protein in mitochondrial fusion. Interestingly, the role of SS31 in improving heart failure and reducing fibrosis is inseparable from the presence of sirtuin3 (Sirt3). We found that in Sirt3KO mice and fibroblasts, the effects of SS31 on improving heart failure and improving fibroblast transdifferentiation were disappeared. Likewise, Sirt3 has direct interactions with proteins critical for mitochondrial fission and fusion. We found that SS31 failed to increase OPA1 expression in both Sirt3KO mice and fibroblasts. Thus, SS31 can alleviate pressure overload-induced heart failure through Sirt3-mediated mitochondrial fusion. This study provides new directions and drug options for the clinical treatment of heart failure caused by pressure overload.<\/jats:p>","DOI":"10.3389\/fcvm.2022.858594","type":"journal-article","created":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T06:05:25Z","timestamp":1651557925000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["SS31 Alleviates Pressure Overload-Induced Heart Failure Caused by Sirt3-Mediated Mitochondrial Fusion"],"prefix":"10.3389","volume":"9","author":[{"given":"Mengying","family":"Suo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Ti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongshuai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peili","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1161\/CIRCRESAHA.116.308688","article-title":"Deletion of interleukin-6 attenuates pressure overload-induced left ventricular hypertrophy and dysfunction","volume":"118","author":"Zhao","year":"2016","journal-title":"Circ Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/cvr\/cvz060","article-title":"Pivotal role of membrane substrate transporters on the metabolic alterations in the pressure-overloaded heart","volume":"115","author":"Geraets","year":"2019","journal-title":"Cardiovasc Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jcmg.2020.05.036","article-title":"Imaging interstitial fibrosis, left ventricular remodeling, and function in stage A and B heart failure","volume":"14","author":"Pezel","year":"2021","journal-title":"JACC Cardiovasc Imaging."},{"key":"B4","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","article-title":"Expert consensus document: mitochondrial function as a therapeutic target in heart failure","volume":"14","author":"Brown","year":"2017","journal-title":"Nat Rev Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1111\/bph.15068","article-title":"The role of mitochondrial dynamics in cardiovascular diseases","volume":"178","author":"Forte","year":"2021","journal-title":"Br J Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.omtn.2021.06.006","article-title":"Therapeutic potential and recent advances on targeting mitochondrial dynamics in cardiac hypertrophy: a concise review","volume":"25","author":"Aung","year":"2021","journal-title":"Mol Ther Nucleic Acids."},{"key":"B7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jacc.2010.12.044","article-title":"Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy","volume":"58","author":"Dai","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"105783","DOI":"10.1016\/j.phrs.2021.105783","article-title":"Mitochondrial dysfunction and beneficial effects of mitochondria-targeted small peptide SS-31 in diabetes mellitus and Alzheimer's disease","volume":"171","author":"Ding","year":"2021","journal-title":"Pharmacol Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.cmet.2015.07.008","article-title":"Reversal of mitochondrial transhydrogenase causes oxidative stress in heart failure","volume":"22","author":"Nickel","year":"2015","journal-title":"Cell Metab."},{"key":"B10","doi-asserted-by":"publisher","first-page":"H1375","DOI":"10.1152\/ajpheart.00053.2015","article-title":"The role of sirtuins in cardiac disease","volume":"309","author":"Matsushima","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.tem.2013.12.001","article-title":"SIRT1 and other sirtuins in metabolism","volume":"25","author":"Chang","year":"2014","journal-title":"Trends Endocrinol Metab."},{"key":"B12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.tcb.2020.09.008","article-title":"Mitochondrial fusion: the machineries in and out","volume":"31","author":"Gao","year":"2021","journal-title":"Trends Cell Biol."},{"key":"B13","first-page":"3258","article-title":"SIRT3 attenuates AngII-induced cardiac fibrosis by inhibiting myofibroblasts transdifferentiation via STAT3-NFATc2 pathway","volume":"9","author":"Guo","year":"2017","journal-title":"Am J Transl Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12929-021-00773-z","article-title":"Elp1 facilitates RAD51-mediated homologous recombination repair via translational regulation","volume":"28","author":"Chen","year":"2021","journal-title":"J Biomed Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1016\/j.jacc.2021.04.028","article-title":"AntimiR-132 Attenuates myocardial hypertrophy in an animal model of percutaneous aortic constriction","volume":"77","author":"Hinkel","year":"2021","journal-title":"J Am Coll Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jcmg.2018.08.040","article-title":"Assessment of subclinical left ventricular dysfunction in aortic stenosis","volume":"12","author":"Dahl","year":"2019","journal-title":"JACC Cardiovasc Imaging."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1161\/CIRCHEARTFAILURE.113.000406","article-title":"Global proteomics and pathway analysis of pressure-overload-induced heart failure and its attenuation by mitochondrial-targeted peptides","volume":"6","author":"Dai","year":"2013","journal-title":"Circ Heart Fail."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.3390\/cells10112937","article-title":"Hormonal regulation of oxidative phosphorylation in the brain in health and disease","volume":"10","author":"Glombik","year":"2021","journal-title":"Cells."},{"key":"B19","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jns.2012.05.030","article-title":"Mitochondria, oxidative stress and neurodegeneration","volume":"322","author":"Federico","year":"2012","journal-title":"J Neurol Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.chest.2019.08.2182","article-title":"Mitochondria and critical illness","volume":"157","author":"Supinski","year":"2020","journal-title":"Chest."},{"key":"B21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11357-016-9933-y","article-title":"Mitochondria and oxidative stress in heart aging","volume":"38","author":"Martin-Fernandez","year":"2016","journal-title":"Age (Dordr)."},{"key":"B22","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/iub.352","article-title":"The mitochondrial bioenergetic capacity of carcinomas","volume":"62","author":"Formentini","year":"2010","journal-title":"IUBMB Life."},{"key":"B23","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.3390\/ijms20194924","article-title":"The role of adipose tissue mitochondria: regulation of mitochondrial function for the treatment of metabolic diseases","volume":"20","author":"Lee","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2337\/dbi18-0016","article-title":"Mitochondrial stability in diabetic retinopathy: lessons learned from epigenetics","volume":"68","author":"Kowluru","year":"2019","journal-title":"Diabetes."},{"key":"B25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.omtn.2020.05.013","article-title":"Exosomal miRNA-320a is released from hAMSCs and regulates SIRT4 to prevent reactive oxygen species generation in POI","volume":"21","author":"Ding","year":"2020","journal-title":"Mol Ther Nucleic Acids."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/bph.13861","article-title":"Hydrogen sulfide pretreatment improves mitochondrial function in myocardial hypertrophy via a SIRT3-dependent manner","volume":"175","author":"Meng","year":"2018","journal-title":"Br J Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1089\/ars.2018.7703","article-title":"Sirt3 deficiency shortens life span and impairs cardiac mitochondrial function rescued by Opa1 gene transfer","volume":"31","author":"Benigni","year":"2019","journal-title":"Antioxid Redox Signal."},{"key":"B28","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1128\/MCB.01483-13","article-title":"SIRT3 deacetylates and activates OPA1 to regulate mitochondrial dynamics during stress","volume":"34","author":"Samant","year":"2014","journal-title":"Mol Cell Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3389\/fncel.2020.00251","article-title":"Elamipretide attenuates pyroptosis and perioperative neurocognitive disorders in aged mice","volume":"14","author":"Zuo","year":"2020","journal-title":"Front Cell Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"110521","DOI":"10.1016\/j.biopha.2020.110521","article-title":"Mitochondria targeted peptide SS-31 prevent on cisplatin-induced acute kidney injury via regulating mitochondrial ROS-NLRP3 pathway","volume":"130","author":"Yang","year":"2020","journal-title":"Biomed Pharmacother."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e55513","DOI":"10.7554\/eLife.55513","article-title":"Late-life restoration of mitochondrial function reverses cardiac dysfunction in old mice","volume":"9","author":"Chiao","year":"2020","journal-title":"Elife."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.3390\/ijms19092782","article-title":"Combined therapy with SS31 and mitochondria mitigates myocardial ischemia-reperfusion injury in rats","volume":"19","author":"Lee","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"eabb7422","DOI":"10.1126\/sciadv.abb7422","article-title":"ROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule","volume":"6","author":"Liu","year":"2020","journal-title":"Sci Adv"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.858594\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T06:05:31Z","timestamp":1651557931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.858594\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,3]]},"references-count":33,"alternative-id":["10.3389\/fcvm.2022.858594"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.858594","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,3]]},"article-number":"858594"}}